Skip to main content
Skip to main content
CCAP logo

Crescent Capital BDC, Inc. (CCAP)

$11.10 $-0.03 (-0.22%) |Strong · 72
Bottom line: BUY — our Council read (64/100) and AI Score (72/100) broadly agree. Strongest signal: Ray Dalio bullish · Biggest watch-out: Ken Griffin bearish.
MCap: $408.81M| P/E Ratio: 27.1| Vol: 233.6K| Target: $14.00 (+26.2%)| 52-wk range: $11.03 – $16.04
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Crescent Capital BDC, Inc. (CCAP) trades at $11.10 with AI Score 72/100 (Grade A). Crescent Capital BDC, Inc. is a business development company specializing in direct investments within the middle market. Market cap: $408.81M, Sector: Financial services.

Price live · AI analysis from May 10, 2026
Crescent Capital BDC, Inc. is a business development company specializing in direct investments within the middle market. The fund focuses on private equity/buyouts and loan fund investments primarily in the United States.

CCAP stock analysis for 2026: Analysts have set a consensus price target of $14.00 for Crescent Capital BDC, Inc., suggesting 26.2% upside from the current price of $11.10. The AI MoonshotScore is 72/100, indicating a bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
BUY 64/100 · B+

CCAP: 4/7 perspectives are bullish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bearish
Jim Simons
Neutral
Izzy Englander
Neutral
Seth Klarman
Bullish
Moon AI
Bullish
Council Score · 8 perspectives · See tabs for details →

Crescent Capital BDC, Inc. (CCAP) Financial Services Profile

CEOJason A. Breaux
HeadquartersLos Angeles, CA, US
IPO Year2020

Crescent Capital BDC, Inc. operates as a business development company, focusing on direct investments in the middle market. Specializing in private equity/buyouts and loan funds within the United States, CCAP offers investors exposure to a diversified portfolio of debt and equity investments in privately held companies.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for CCAP?

Crescent Capital BDC, Inc. presents a notable research candidate due to its focus on direct lending to middle-market companies, a segment often underserved by traditional lenders. With a dividend yield of 10.04% as of May 10, 2026, CCAP offers attractive income potential for investors seeking yield in a low-interest-rate environment. The company's experienced management team and affiliation with Crescent Capital Group LP provide a competitive advantage in sourcing and managing investments. A potential catalyst is the anticipated increase in demand for private credit as banks tighten lending standards, which could drive higher investment volumes and improved portfolio performance for CCAP. However, investors should be aware of the risks associated with investing in illiquid securities and the potential for credit losses in a challenging economic environment. The company's P/E ratio of 27.1 suggests a reasonable valuation relative to its earnings.

Based on FMP financials and quantitative analysis

CCAP Key Highlights

  • Market capitalization of $408.81M indicates a mid-sized BDC with potential for growth.
  • P/E ratio of 27.1 suggests a reasonable valuation compared to peers in the asset management industry.
  • Profit margin of 20.9% demonstrates solid profitability in its investment activities.
  • Gross margin of 43.2% reflects efficient management of investment-related expenses.
  • Dividend yield of 10.04% provides an attractive income stream for investors.

Who Are CCAP's Competitors?

CCAP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ARCC Ares Capital Corporation $18.61 -0.62% $13.37B 79
MAIN Main Street Capital Corporation $52.43 +0.91% $4.88B 73
TCPC BlackRock TCP Capital Corp. $3.24 -3.48% $272.11M
NXDT NexPoint Diversified Real Estate Trust $5.53 +3.08% $285.77M 73
GENB Generate Biomedicines, Inc. $17.03 -2.18% $2.18B 72
SII Sprott Inc. $118.11 +2.72% $3.05B 71
TPZ Tortoise Electrification Infrastructure ETF $21.82 +0.74% $128.52M 70
IDDTF AB Industrivärden (publ) $59.80 +74.60% $25.83B 70

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CCAP's Key Strengths?

  • Experienced management team with a proven track record.
  • Strong relationships with private equity sponsors.
  • Diversified investment portfolio across various industries.
  • Attractive dividend yield for income-seeking investors.

What Are CCAP's Weaknesses?

  • Exposure to credit risk in middle-market lending.
  • Reliance on external management by Crescent Cap Advisors, LLC.
  • Limited liquidity of investments in private companies.
  • Sensitivity to interest rate fluctuations.

What Could Drive CCAP Stock Higher?

  • Potential increase in demand for private credit due to tighter bank lending standards.
  • Continued growth in the middle-market financing market.
  • Strategic partnerships with other financial institutions.
  • Diversification into new industries and geographies.

What Are the Key Risks for CCAP?

  • Financial-distress signal — its Altman Z-Score of 0.24 sits in the distress zone (elevated bankruptcy risk).
  • Rich valuation — a P/E of 27.1 runs well above the Financial Services sector’s ~18x, leaving little room for a miss.
  • Economic downturn leading to increased credit losses.
  • Increased competition from other BDCs and private credit funds.
  • Changes in regulations affecting the BDC industry.
  • Sensitivity to interest rate fluctuations.
  • Illiquidity of investments in private companies.

What Are the Growth Opportunities for CCAP?

  • Expansion of Direct Lending Activities: Crescent Capital BDC can expand its direct lending activities to capture a larger share of the middle-market financing market. The market for private credit is estimated to reach $1.4 trillion by 2028, offering significant growth potential. By leveraging its existing relationships with private equity sponsors and management teams, CCAP can source new investment opportunities and increase its portfolio size. Timeline: Ongoing.
  • Strategic Partnerships: Forming strategic partnerships with other financial institutions and private equity firms can provide Crescent Capital BDC with access to a broader network of deal flow and expertise. Collaborating with partners can also enable CCAP to participate in larger transactions and diversify its investment portfolio. The market for strategic alliances in the financial services industry is expected to grow at a rate of 6% annually through 2027. Timeline: Upcoming, within the next 12-24 months.
  • Diversification into New Industries: Diversifying its investment portfolio into new industries can reduce Crescent Capital BDC's exposure to sector-specific risks and enhance its long-term growth prospects. The company can target industries with strong growth potential, such as technology, healthcare, and renewable energy. The global market for renewable energy investments is projected to reach $2.15 trillion by 2027. Timeline: Ongoing.
  • Geographic Expansion: Expanding its geographic footprint beyond the United States can provide Crescent Capital BDC with access to new investment opportunities and diversify its revenue streams. The company can target developed markets with stable economies and favorable regulatory environments, such as Europe and Canada. The global market for private credit is expected to grow at a rate of 8% annually through 2028, driven by increasing demand from international markets. Timeline: Potential, within the next 3-5 years.
  • Increased Focus on Equity Investments: Increasing its focus on equity investments can enhance Crescent Capital BDC's potential for capital appreciation and generate higher returns over the long term. The company can target companies with strong growth potential and attractive valuations. The global market for private equity investments is projected to reach $8.24 trillion by 2028. Timeline: Ongoing.

What Opportunities Does CCAP Have?

  • Expansion of direct lending activities in the growing private credit market.
  • Strategic partnerships with other financial institutions.
  • Diversification into new industries and geographies.
  • Increased focus on equity investments for capital appreciation.

What Threats Does CCAP Face?

  • Economic downturn leading to increased credit losses.
  • Increased competition from other BDCs and private credit funds.
  • Changes in regulations affecting the BDC industry.
  • Rising interest rates increasing borrowing costs for portfolio companies.

What Are CCAP's Competitive Advantages?

  • Established relationships with private equity sponsors and management teams.
  • Experienced investment team with expertise in private equity, leveraged finance, and restructuring.
  • Affiliation with Crescent Capital Group LP, a leading alternative credit investment firm.
  • Diversified investment portfolio across various industries and geographies.

What Does CCAP Do?

Crescent Capital BDC, Inc. is a business development company (BDC) that specializes in providing financing to middle-market companies. The firm focuses on direct investments, primarily in the form of debt and equity, to support buyouts, acquisitions, growth capital, and recapitalizations. Crescent Capital BDC aims to generate both current income and capital appreciation through its investments. The company's investment strategy targets companies with established business models, experienced management teams, and strong cash flow generation. Crescent Capital BDC operates primarily in the United States, focusing on companies with enterprise values typically ranging from $50 million to $1 billion. The company's portfolio is diversified across various industries, including business services, healthcare, manufacturing, and technology. Crescent Capital BDC seeks to partner with private equity sponsors and management teams to provide flexible financing solutions tailored to the specific needs of each portfolio company. The company's investment team has extensive experience in private equity, leveraged finance, and restructuring, enabling it to effectively evaluate investment opportunities and manage risk. Crescent Capital BDC is externally managed by Crescent Cap Advisors, LLC, an affiliate of Crescent Capital Group LP, a leading alternative credit investment firm with approximately $40 billion of assets under management as of December 31, 2025.

What Products and Services Does CCAP Offer?

  • Provides direct lending to middle-market companies.
  • Invests in private equity buyouts and loan funds.
  • Offers financing for acquisitions, growth capital, and recapitalizations.
  • Generates income through interest payments and capital appreciation.
  • Partners with private equity sponsors and management teams.
  • Manages a diversified portfolio of debt and equity investments.
  • Focuses on companies with established business models and strong cash flow.

How Does CCAP Make Money?

  • Generates revenue through interest income from debt investments.
  • Realizes capital gains from equity investments.
  • Externally managed by Crescent Cap Advisors, LLC, an affiliate of Crescent Capital Group LP.
  • Invests in middle-market companies with enterprise values typically ranging from $50 million to $1 billion.

What Industry Does CCAP Operate In?

Crescent Capital BDC operates within the asset management industry, specifically focusing on business development companies (BDCs). The BDC sector has experienced growth in recent years as middle-market companies seek alternative sources of financing outside of traditional banks. The competitive landscape includes other BDCs, private credit funds, and direct lending platforms. Market trends indicate increasing demand for private credit due to stricter bank regulations and a growing number of middle-market companies. Crescent Capital BDC is positioned to capitalize on these trends through its established platform and experienced investment team.

Who Are CCAP's Key Customers?

  • Middle-market companies seeking financing for various purposes.
  • Private equity sponsors looking for financing partners.
  • Institutional investors seeking exposure to private credit and equity investments.
  • Companies in business services, healthcare, manufacturing, and technology industries.
AI Confidence: 73% Updated: May 10, 2026

Crescent Capital BDC, Inc. Financial Trajectory

Crescent Capital BDC, Inc. (CCAP) reported $25.6M in revenue for Q1 2026, a decline of 41.7% compared to the prior quarter. The company recorded a net loss of $15.5M, with diluted EPS of $-0.42. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Financial Services. Across the four most recent quarters, CCAP averaged $0.10 in diluted EPS.

Company Profile

Crescent Capital BDC, Inc. operates in the Asset Management industry within the Financial Services sector. It is headquartered in Los Angeles, US. The company is led by CEO Jason A. Breaux. CCAP has traded publicly since 2020.

How Crescent Capital BDC, Inc. Is Valued

Crescent Capital BDC, Inc. carries a market capitalization of $408.81M, placing it in the small-cap category. Relative to its peer group, CCAP's quantitative score of 72/100 is roughly in line with the peer average of 74/100.

ROE 2%Key Financial Metrics

Return on equity for Crescent Capital BDC, Inc. stands at 2.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.9%, showing how much profit it generates from its asset base. CCAP trades at a trailing price-to-earnings ratio of 27.11, above the Financial Services sector average of ~18x. Its free cash flow yield is 15.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 3.6%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9Financial Health

Crescent Capital BDC, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 0.24 places it in the distress zone, a signal of elevated financial risk.

FY2026 estForward Outlook

Wall Street analysts project Crescent Capital BDC, Inc. revenue of about $149.4M for fiscal 2026, with EPS near $1.56. The estimate reflects 4 contributing analysts.

CCAP Financials

Fundamental Snapshot

Revenue Growth (FY)
+9.7%
Net Income Growth (FY)
-53.1%
EPS Growth (FY)
-53.3%
Free Cash Flow Growth (FY)
-9.7%
P/E (TTM)
7.5
Return on Equity (TTM)
+2.2%
Current Ratio
1.5

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Experienced management team with a proven track record.
  • Strong relationships with private equity sponsors.
  • Diversified investment portfolio across various industries.
  • Attractive dividend yield for income-seeking investors.

Bear Case

  • Exposure to credit risk in middle-market lending.
  • Reliance on external management by Crescent Cap Advisors, LLC.
  • Limited liquidity of investments in private companies.
  • Sensitivity to interest rate fluctuations.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2026 $26M -$16M -$0.42
Q4 2025 $44M $8M $0.23
Q3 2025 $23M $7M $0.19
Q2 2025 $32M $15M $0.41

Based on FMP financials and quantitative analysis

CCAP Latest News

CCAP Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CCAP.

Price Targets

Consensus target: $14.00

CCAP MoonshotScore

72/100

What does this score mean?

The MoonshotScore rates CCAP's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Jason A. Breaux

CEO

Jason A. Breaux serves as the Chief Executive Officer of Crescent Capital BDC, Inc. He has extensive experience in the credit and private equity markets. Prior to joining Crescent Capital, he held various leadership positions at leading financial institutions, including roles in investment banking, leveraged finance, and restructuring. Breaux's background includes a strong understanding of credit analysis, portfolio management, and capital markets. He holds an MBA from a top-tier business school and a bachelor's degree in finance.

Track Record: Since assuming the role of CEO, Jason A. Breaux has focused on enhancing Crescent Capital BDC's investment strategy and improving its portfolio performance. He has overseen the expansion of the company's direct lending activities and the diversification of its investment portfolio. Under his leadership, CCAP has maintained a strong dividend yield and generated attractive returns for shareholders. Breaux has also emphasized risk management and credit quality in the company's investment decisions.

What Investors Ask About Crescent Capital BDC, Inc. (CCAP) — Financial Services

What does Crescent Capital BDC, Inc. do?

Crescent Capital BDC, Inc. operates as a business development company, providing financing solutions to middle-market companies. It specializes in direct lending, private equity buyouts, and loan fund investments, primarily within the United States. The company aims to generate both current income and capital appreciation through its investments. CCAP partners with private equity sponsors and management teams to provide flexible financing solutions tailored to the specific needs of each portfolio company, focusing on companies with established business models and strong cash flow generation.

What do analysts say about CCAP stock?

Analyst coverage of Crescent Capital BDC, Inc. typically focuses on its dividend yield, portfolio credit quality, and management's ability to generate attractive returns. Consensus estimates suggest moderate growth in net investment income over the next few years, driven by increased lending activity and portfolio diversification. Valuation metrics, such as price-to-book value and price-to-earnings ratio, are often compared to peers in the BDC industry. Investors should monitor analyst reports for updates on CCAP's financial performance and strategic initiatives. No buy or sell recommendations are being made.

What are the main risks for CCAP?

The main risks for Crescent Capital BDC, Inc. include credit risk associated with lending to middle-market companies, which may be more vulnerable to economic downturns. Interest rate risk is also a concern, as rising rates could increase borrowing costs for portfolio companies and reduce CCAP's net interest margin. Regulatory changes affecting the BDC industry could also impact the company's operations and profitability. Additionally, the illiquidity of investments in private companies poses a risk, as it may be difficult to exit investments quickly if needed.

What are the key factors to evaluate for CCAP?

Crescent Capital BDC, Inc. (CCAP) holds an AI score of 72/100 (high). P/E: 27.1x vs the S&P 500's ~20-25x. Analysts target $14.00 (+26%). Not financial advice.

How frequently does CCAP data refresh on this page?

CCAP prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven CCAP's recent stock price performance?

Crescent Capital BDC, Inc. (CCAP) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team with a proven track record. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CCAP overvalued or undervalued right now?

Crescent Capital BDC, Inc. (CCAP) trades at 27.1x earnings. Analysts target $14.00 (+26%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying CCAP?

Before investing in Crescent Capital BDC, Inc. (CCAP), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Investment decisions should be based on individual risk tolerance and financial circumstances.
Data Sources

Popular Stocks